Pharmaceutical Regulation
What This Page Covers
This page collects the 4 public records POLISCOPE has tagged with “Pharmaceutical Regulation”. Coverage spans bills - each decoded into plain English and linked to its primary source. It most often overlaps with Reproductive Health, Federal Legislation, and Abortion Access.
Active Bills
Recent Activity
No recent activity found for this topic in the available records yet.
Browse recent local activity →Finance Signals
No finance signals found for this topic in the available records yet.
Open the Money page to search by entity, donor, or PAC.
Reported financial relationships and timing signals. This does not prove motive or influence.
Key Actors
- 01Katharine MacGregorperson1 mentions
- 02House Committee on the Judiciaryorganization1 mentions
- 03Markus H. Meierperson1 mentions
- 04Paul Atkinsperson1 mentions
- 05Luke Pettitperson1 mentions
- 06Eric Matthew Uelandperson1 mentions
- 07Energy and Commerce Committeeorganization1 mentions
- 08Committee on the Judiciaryorganization1 mentions
- 09Patrick David Davisperson1 mentions
- 10Scott Gottliebperson1 mentions
Connections Preview
Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.
- Topic to billsSafeguarding Women from Chemical Abortion Act introduced in U.S. House
- Topic to peopleKatharine MacGregor, Markus H. Meier, Paul Atkins (+4 more)
- Topic to orgsHouse Committee on the Judiciary, Energy and Commerce Committee, Committee on the Judiciary
Source Trail
Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.
- Mar 12, 2026Federal BillSafeguarding Women from Chemical Abortion Act introduced in U.S. House
- Mar 31, 2025congressional recordUpcoming Senate Committee Meetings: April 2–9, 2025
- Jan 1, 2018hearing transcriptCongressional Hearing on FDA Approval and Antitrust Issues
Showing 3 of 4 source records.